Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density

Henry G. Bone, Michael R. McClung, Christian Roux, Robert R. Recker, John A. Eisman, Nadia Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Arthur C. Santora, B. Avery Ince

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)937-947
JournalJournal of Bone and Mineral Research
Volume25
Issue number5
DOIs
Publication statusPublished - May 2010

Keywords

  • BONE MINERAL DENSITY
  • CATHEPSIN K
  • CLINICAL TRIAL
  • ODANACATIB
  • OSTEOPOROSIS
  • PHASE 2B
  • POSTMENOPAUSAL WOMEN

Cite this